Pivotal Financial Consulting, LLC

Strategic Financial Consultant

Serving the Clinical Research Industry

Home
About Me
News
Pivotal Blog
Exhibits
Contact Me
More

Posts Coming Soon

Explore other categories in this blog or check back later.

Biotech - Don't Call It a Comeback

COVID-19 - Clinical Trial Impact

COVID-19 - Assessing the Data

CRO Account Directors Make A Big Impact

Turnover - Is it Always Bad?

Mid-Size CRO Competitive Landscape

Recent Biotech IPO Analysis

Recent Biotech IPO Analysis

Biotech FDA Approvals Peak

CRO Utilization - Part #2

CRO Utilization Part #1

Biotech's Impact on Drug Development

Effective Communication – The Overlooked CRO Advantage

Where CRO Size Doesn't Matter - Glassdoor.com

Project Leaders: The Unsung CRO Heroes

CRO: Does Size Matter?

Contractors vs. Employees: When CROs Outsource

Quick Impact - PRA Acquires Symphony Health

Parexel Backlog Adjustments & Burn Rates

Simple Metrics Clinical Research Organizations Should Utilize - But Don't

Pediatric Clinical Trials - The Niche That Shouldn't Be a Niche